HAART to heart: HIV-related cardiomyopathy and other cardiovascular complications

AACN Advanced Critical Care

Volumn 17, Issue 1, 2006, Pages 18-29

  Dakin, Cynthia L ^a   O'Connor, Catherine A ^a   Patsdaughter, Carol A ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Collaboration; Dilated cardiomyopathy; HIV related cardiac complications

Indexed keywords

AFRICAN AMERICAN; CARDIOVASCULAR DISEASE; CASE REPORT; CD4 LYMPHOCYTE COUNT; COMMUNITY HEALTH NURSING; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; HEALTH; HEALTH CARE; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOME CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; MIDDLE AGED; NURSE ATTITUDE; NURSING ASSESSMENT; PATIENT REFERRAL; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; STATISTICS; SUBSTANCE ABUSE; TREATMENT REFUSAL; UNITED STATES; VIROLOGY;

AFRICAN AMERICANS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR DISEASES; CD4 LYMPHOCYTE COUNT; COMMUNITY HEALTH NURSING; COMPREHENSIVE HEALTH CARE; ELECTROCARDIOGRAPHY; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HOME CARE SERVICES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NURSE'S ROLE; NURSING ASSESSMENT; REFERRAL AND CONSULTATION; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT REFUSAL; UNITED STATES; WORLD HEALTH;

EID: 33746085689     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Henry J. Kaiser Foundation. More than 1 million HIV-positive people living in United States; nearly half of cases among African Americans. Available at: http://www.thebodypro.com/kaiser/2005/jun14 05/hiv_prevalence.html?mb45h. Accessed July 10, 2005.
2. Prendergast BD. HIV and cardiovascular medicine. Heart. 2003;89:793-800.
3. Fisher SD, Lipshultz SE. Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci. 2001;946:13-22.
4. O'Neill JO, Bott-Silverman C. Dilated and restrictive cardiomyopathies. Available at: http://www.clevelandclinicmeded.com/diseasemanagement/cardiology/ cardiomyopathy/cardiomyopathy.htm. Accessed June 29, 2005.
5. Currie PF, Boon NA. Immunopathogenesis of HIV-related heart muscle disease: current perspectives. AIDS. 2003;17(suppl 1):S21-S28.
6. Barbaro G. Cardiovascular manifestations of HIV infection. Circ J AmHeart Assoc. 2002;106:1420-1425.
7. Nanavati KA, Fisher SD, Miller TL, Lipshultz SE. HIV-related cardiovascular disease and drug interactions. Am J Cardiovasc Drugs. 2004;4(5):315-324.
8. Werneck GL, Mesquita ET, Romeo LJM, Ribeiro, ML. Doppler echocardiographic evaluation of HIV-positive patients in different stages of the disease. Arquivos Brasileiros de Cardiologia. 1999;73:163-168.
9. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med. 1998;339:1093-1099.
10. Jaber S, Chanques C, Borry J, Souche B, Verdier R, Perrigault P, Eledjam E. Cytomegalovirus infection in critically ill patients. Chest. 2005;127:233-241.
11. Sundstrom JB, Aftab AA. Pathogenesis of AIDS-related dilated cardiomyopathy. AIDS Review. 2001;(3)36-43.
12. Valencia E, Miro J. Endocarditis in the setting of HIV infection. AIDS Rev. 2004;6(2):97-106.
13. Nahass RG, Weinstein MP, Bartels J. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type-1-negative and -positive patients. J Infect Dis. 1990;162:967-970.
14. Cicalini S, Forcina G, DeRosa FG. Infective endocarditis in patients with human immunodeficiency virus infection. J Infect. 2001;42:267-271.
15. Miro JM, delRio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003;21(2):167-184.
16. Letts DP, López-Candales A. Atypical echocardiographic findings of endocarditis in an immunocompromised patient. Echocardiography. 2004;21(8):715-719.
17. Hoit BD, Faulx MD. Diseases of the pericardium. In: Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's The Heart, 11th ed. New York, NY: McGraw-Hill;2004:1977-2000.
18. Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS. 2003;17(suppl 1):S12-S20.
19. Heidenreich PA, Eisenberg MJ, Kee LL, et al. Pericardial effusion in AIDS. Incidence and survival. Circulation. 1995;92:3229-3234.
20. Jenson HB, Pollock BH. Cardiac cancers in HIV-infected patients. In: Lipshultz SE, ed. Cardiology AIDS. New York, NY: Chapman and Hall; 2001:235-263.
21. Silver MA, Macher CM. Cardiac involvement by Kaposi's sarcoma in acquired immune deficiency syndrome (AIDS). Amer J Cardiol. 1984;(53):983-985.
22. Van der valk M, Reiss P. Lipid profiles associated with antiretroviral drug choices. Current Options Infect Dis. 2003;16(1):19-23.
23. Materzky S, Domingo M, Kar S. Acute myocardial infarction in human immunodeficiency virus- infected patients. Arch Intern Med. 2003;163(4):457-460.
24. Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS. 2003;17(supp1):S12-S20.
25. Wills TS, Nadler JP, Somboonwit, C et al. Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. AIDS Read. 2004;14(6):305-310, 313-315.
26. Chong GPE. Cardiovascular complications of HIV infection. Trinity Student Med J. 2004;(5):31-36.
27. Vittecoq D, Eseaut L, Chironi G. Coronary heart disease in HIV -infected patients in the highly active antiretroviral treatment era. AIDS. 2003;17(supp1):S70-S76.
28. Lipshultz SE, Fisher SD, Lai WW, Miller LI. Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS. 2003;17(supp1):S96- S122.
29. Kilborn M. Education toolbox: Practical approach to long QT syndrome and Torsades de Pointes. Arizona CERT: Center for Education and Research Therapeutics. 2005. Available at: http://www.torsades.org/medical-pros/ education/practical-approach.htm. Accessed July 4, 2005.
30. Maron DJ, Grundy SM, Ridker PM, Pearson TA. Dyslipidemia, other risk factors, and the prevention of coronary heart disease. IN: Fuster VF, Alexander RW, O'Rourke RA, eds. The Heart, 11th ed. New York: New York: McGraw-Hill; 2004:1093-1122.
31. Niaura R, Shadel WG, Moeeow K, Flanigan T, Abrams DB. Smoking among HIV-positive persons. Ann Behav Med. 1999;21(suppl):S116.
32. Barbaro G, Fisher SD, Giancaspro G, Lipshultz SE. HIV-associated cardiovascular complications: a new challenge for emergency physicians. Am J Emerg Med. 2001;19(7):566-574.
33. Brucato A, Colombo T, Bonacina E, et al. Fulminant myocarditis during HIV seroconversion: recovery with temporary left ventricular mechanical assistance. Ital Heart J. 2004;5(3):228-231.
34. Peacock WF. The B-type natriuretic peptide assay: a rapid test for heart failure. Cleveland Clinic J Med. 2002;69(3):243-251.
35. Ku L, Feiger J, Taylor M, Mestroni L. Familial dilated cardiomyopathy. Circ J Am Heart Assoc. 2003;108:e118-e121.
36. Cleland JGF, Findlay I, Jafri S, et al. The warfarin/aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Amer Heart J. 2004;148(1):157-64.
37. Cleland JGF, Ghosh J, Freemantle N, et al. Clinical trials update and cumulative meta-analyses from the 38. American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS and cardiac resynchronization therapy in heart failure. Eur J Heart Failure. 2004;6:501-508.
38. Mohan SB, Parker M, Wehbi M, Douglass P. Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. Cleveland Clinic J Med. 2002;69(6):481-487.
39. Lipshultz SE, Orav EJ, Sanders AP, Colan SD. Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circ J Am Heart Assoc. 1995;92:2220-2225.
40. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90:464-470.
41. Patsdaughter CA, O'Connor CA, Grindel CG, Taveira PF, Mancusi MA. Circle of care: Beyond HIV counseling and testing. J Healthcare Poor Underserved. 2001;12:381-391.
42. Cameron JF, Patsdaughter CA, O'Connor C. Is the cost of home care greater than the cost of nonadherence? Catrina's journey through the maze of HIV medications and managed care. Home Healthcare Nurse. 2000;18(10):588-594.
43. O'Connor CA, Medeiros M, DeSantis JP, Patsdaughter CA, Casale C, Balram SP. Special delivery: when the pills "absolutely, positively" can't be delivered at home. J Cult Diversity. 2004;11(2):44-48.
44. DeSantis JP, Patsdaughter CA. HIV/AIDS: A changing course. Adv Nurse Practitioners. 2005;13(4):47-48, 50.
45. Institute of Medicine, Smedley BD, Stith AY, Nelson AR, ed. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health. Washington, DC: National Academies Press; 2003.
46. Krauss BJ, Goldsamt L, Bula E, et al. The white researcher in the multicultural community: lessons in HIV prevention education learned in the field. J Health Educ. 1997;28(6):67-71S.
47. Blanchard DG, Hagenhoff C, Chow LC, McCann HA, Dittrich HC. Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: a serial echocardiographic study. J Am Coll Cardiol. 1991;17(6):1270-1276.
48. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV infection prognostic implications. BMJ. 1994;309(6969):1605-1607.
49. Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am Heart J. 1987;113(3):773-784.
50. Himmelman RB, Dohrmann M, Goodman P, et al. Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome. Am J Cardiol. 1989;64:1396-1399.
51. Tabib A, Leroux C, Mornex JF, Loire R. Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus- positive patients. Coronary Artery Dis. 2000;11:41-46.
52. Constans J, Marchand JM, Conri C, et al. Asymptomatic atherosclerosis in HIV-positive patients: a case-control ultrasound study. Ann Internal Med. 1995;27:683-685.
53. Freeman R, Roberts MS, Friedman LS, et al. Autonomic function and human immunodeficiency virus infection. Neurology. 1990;40:575-580.